The vaccine production companies in nan play a crucial role in global health. They develop and manufacture vaccines to combat infectious diseases, ensuring that communities have access to immunizations. The industry includes established giants and emerging biotech firms focused on innovative solutions. These companies vary in size and specialization, often prioritizing research and development to enhance vaccine efficacy. As the world faces challenges like pandemics, the importance of robust vaccine production is rising. Many firms are incorporating advanced technologies, such as mRNA platforms, to meet both current and future health needs, thereby revolutionizing how we approach vaccinations.


Within this list, you'll find a variety of vaccine production companies, ranging from large-scale manufacturers to innovative biotech firms. Headquartered primarily in India, Europe, and South Africa, these companies were founded between the 1940s and 2020s. They typically employ between 100 and 5,000 employees and specialize in a variety of vaccines for infectious diseases. Notable examples include Serum Institute of India, which is well-known for its extensive vaccine portfolio, and Bharat Biotech, recognized for its significant contributions during the COVID-19 pandemic.


Read on to discover key vaccine production companies.


Top 27 Vaccine Production Companies


1. Serum Institute of India Pvt. Ltd.


Serum Institute of India Pvt. Ltd., based in Pune, Maharashtra, is a prominent vaccine manufacturer that has been operational since 1966. The company focuses on producing immuno-biologicals and offers a wide range of vaccines targeting various infectious diseases. Their product line includes vaccines for measles, mumps, rubella, DTP, hepatitis, and influenza, among others. Serum Institute is also known for its significant role in the global response to the COVID-19 pandemic, having developed COVISHIELD, which is based on the AstraZeneca vaccine. The company is dedicated to research and development, continually working to improve vaccine safety and efficacy. With a workforce of over 5,000 employees, Serum Institute is a key player in both domestic and international vaccine supply chains, catering to healthcare providers and public health organizations worldwide.


2. Bharat Biotech

  • Website: bharatbiotech.com
  • Ownership type: Venture Capital
  • Headquarters: Hyderabad, Telangana, India
  • Employee distribution: India 99%
  • Latest funding: Other (Grant), $14.1M, June 2020
  • Founded year: 1996
  • Headcount: 1001-5000
  • LinkedIn: bharat-biotechil

Bharat Biotech International Limited, based in Hyderabad, Telangana, India, is a biotechnology company that specializes in the development and manufacturing of vaccines and biotherapeutics. Established in 1996, the company has focused on creating innovative solutions to combat infectious diseases, particularly in underserved regions. Bharat Biotech has made significant strides in vaccine technology, producing notable products such as COVAXIN, India's first indigenous COVID-19 vaccine, and ROTAVAC, a vaccine for rotavirus. The company operates with a strong emphasis on research and development, which has led to the creation of over 220 patents. Their manufacturing facilities are compliant with international standards, having received approvals from the USFDA, KFDA, and WHO. Bharat Biotech's mission is to deliver affordable and high-quality vaccines, aiming to improve health outcomes globally, especially in developing countries. The company has also received funding, including a grant of $14.1 million in June 2020, to support its initiatives.


3. Biological E. Limited

  • Website: biologicale.com
  • Ownership type: Venture Capital
  • Headquarters: Hyderabad, Telangana, India
  • Employee distribution: India 100%
  • Latest funding: $50.0M, October 2021
  • Founded year: 1953
  • Headcount: 1001-5000
  • LinkedIn: biological-e--ltd

Biological E. Limited, based in Hyderabad, Telangana, India, is a biotechnology and biopharmaceutical company established in 1953. The firm specializes in the production of vaccines and biologics, aiming to provide affordable healthcare solutions. Over the years, Biological E. has transitioned from manufacturing liver extracts and anti-coagulants to focusing on vaccines, launching its Biotechnology Division in 1962. The company has developed a range of vaccines, including those for DPT, hepatitis, and COVID-19, with CORBEVAX being a notable recent addition. This protein sub-unit vaccine has received Emergency Use Authorization in India, showcasing the company's innovative capabilities. With a workforce of over 4,000 employees, Biological E. Limited continues to play a crucial role in the healthcare sector, supplying essential vaccines to government hospitals and public health organizations. The company has also secured significant funding, with a reported amount of $50 million in October 2021, indicating ongoing investment in its operations and research.


4. Biovac

  • Website: biovac.co.za
  • Ownership type: Corporate
  • Headquarters: Cape Town, Western Cape, South Africa
  • Employee distribution: South Africa 99%
  • Latest funding: June 2016
  • Founded year: 2003
  • Headcount: 201-500
  • LinkedIn: the-biovac-institute

Biovac is a biopharmaceutical company based in Cape Town, South Africa, founded in 2003. The company focuses on the development and manufacturing of vaccines, playing a crucial role in supplying vaccines for the Expanded Programme on Immunisation in South Africa. With a workforce of approximately 472 employees, Biovac is dedicated to enhancing local vaccine production capabilities to meet the healthcare needs of the region. They have invested significantly in infrastructure and skills development, securing technology transfers from international pharmaceutical companies. Biovac's product offerings include vaccines for diseases such as tuberculosis, measles, pneumonia, and hepatitis B, among others. They are committed to making vaccines accessible and affordable, not only in South Africa but also in neighboring countries within the South African Development Community (SADC). Their partnerships with organizations like the World Health Organization and various international vaccine manufacturers underscore their role in advancing vaccine production in Africa.


5. Indian Immunologicals Limited


Indian Immunologicals Limited (IIL), founded in 1982 and based in Hyderabad, Telangana, is a private healthcare company focused on the development and manufacturing of vaccines. With a workforce of approximately 1,785 employees, IIL operates one of the largest plants for veterinary vaccines globally. The company produces a wide range of vaccines aimed at preventing diseases in livestock and humans. IIL is particularly known for its contributions to public health, supplying vaccines for India's Universal Immunization Programme and developing innovative products like the purified vero cell rabies vaccine. The company has a strong research and development pipeline, collaborating with national and international institutes to enhance its offerings. IIL exports its products to over 50 countries, showcasing its global reach and commitment to improving health outcomes. Their mission is to innovate and market quality healthcare products that improve and extend lives, reflecting their dedication to both animal and human health.


6. SINERGIUM Biotech

  • Website: sinergiumbiotech.com
  • Ownership type: Private
  • Headquarters: Garin, Buenos Aires, Argentina
  • Employee distribution: Argentina 100%
  • Founded year: 2011
  • Headcount: 201-500
  • LinkedIn: sinergium-biotech

SINERGIUM Biotech is an Argentine biopharmaceutical company founded in 2011, located in Garin, Buenos Aires. The company specializes in the research, development, production, and commercialization of vaccines and complex biopharmaceutical products. With a workforce of approximately 267 employees, SINERGIUM operates a state-of-the-art manufacturing facility that adheres to international Good Manufacturing Practices (GMP). The company is committed to improving public health by providing high-quality medical solutions to healthcare providers and government health agencies. SINERGIUM has formed strategic alliances with both national and international laboratories, allowing for the transfer of cutting-edge technologies and the production of vaccines that were previously imported. Their involvement in the production of mRNA vaccines, as part of a WHO initiative, highlights their role in advancing vaccine accessibility in Latin America. The company aims to be a key player in the local and international markets for biotechnological products, focusing on quality, efficiency, and innovation.


7. AJ Vaccines

  • Website: ajvaccines.com
  • Ownership type: Private
  • Headquarters: Frederiksberg, Frederiksberg, Denmark
  • Employee distribution: Denmark 100%
  • Founded year: 2017
  • Headcount: 501-1000
  • LinkedIn: aj-vaccines

AJ Vaccines A/S, based in Frederiksberg, Denmark, is a healthcare solutions provider that focuses on the development and manufacturing of vaccines, diagnostics, and therapeutic solutions. Founded in 2017, the company emerged from the divestment of vaccine production by Statens Serum Institut, which has a long-standing history in public health. AJ Vaccines is dedicated to enhancing global health through its innovative products, which include vaccines for infectious diseases such as diphtheria, pertussis, polio, and tuberculosis, as well as diagnostic tools. The company collaborates with international health organizations, contributing to disease control efforts in over 50 countries. Their involvement in the Childhood Vaccination Programme and the WHO Global Polio Eradication Initiative highlights their commitment to addressing significant health challenges. With a workforce of approximately 538 employees, AJ Vaccines aims to ensure that people worldwide have access to effective vaccination and therapeutic options.


8. Vabiotech

  • Website: vabiotech.com.vn
  • Ownership type: Private
  • Headquarters: Trung Hoà, Hanoi, Vietnam
  • Founded year: 2000
  • Headcount: 1-10
  • LinkedIn: vabiotech

Vabiotech, officially known as Công ty TNHH MTV Vắc xin và Sinh phẩm số 1, is a private biotechnology firm based in Hanoi, Vietnam. Established in 2000, Vabiotech focuses on the production of vaccines and biological products, catering to healthcare providers and government health departments. The company is known for its production of vaccines such as HAVAX® for Hepatitis A, Gene-HBvax for Hepatitis B, JEVAX® for Japanese Encephalitis, and mORCVAX for oral Cholera. Vabiotech is also involved in research and development, aiming to innovate and enhance vaccine technology. They have a commitment to quality, operating under stringent international standards, including WHO-GMP and ISO 9001:2015. Vabiotech collaborates with various international partners to ensure the security of vaccine supply and to advance their R&D initiatives, which are crucial for addressing public health challenges in Vietnam and beyond.


9. FORT Biopharmaceutical company


FORT Biopharmaceutical company, based in Moscow, Russia, is a private biopharmaceutical firm established in 2006. The company focuses on producing vaccines for the prevention of infectious diseases, catering to healthcare professionals and distributors. FORT is dedicated to ensuring public health through effective vaccination solutions, and it operates under stringent regulatory standards. The company has developed notable products, including the four-valent influenza vaccine 'Ультрикс Квадри', which has shown high efficacy and is approved for use across various demographics. FORT's production facilities are equipped to meet international quality standards, and they have been involved in significant vaccination campaigns, including those against influenza and COVID-19. Their commitment to quality control and environmental responsibility further underscores their operational integrity in the biopharmaceutical sector.


10. Hipra

  • Website: hipra.com
  • Ownership type: Private
  • Headquarters: Amer, Catalonia, Spain
  • Employee distribution: Spain 50%, Brazil 8%, India 7%, Other 35%
  • Founded year: 1954
  • Headcount: 1001-5000
  • LinkedIn: hipra

Hipra, founded in 1954 and headquartered in Amer, Catalonia, Spain, is a private biotechnology company with a workforce of approximately 1,845 employees. The company specializes in the research, production, and commercialization of vaccines aimed at both animal and human health. Hipra has made significant strides in innovative vaccine development, including a COVID-19 vaccine, showcasing their ability to respond to urgent health needs. Their product portfolio also includes solutions for digestive health, reflecting their commitment to addressing various health challenges. With a strong international presence, Hipra operates in over 100 countries through a network of subsidiaries, ensuring that their vaccines reach a global audience. The company has established itself as a key player in the vaccine industry, focusing on prevention and health improvement.


11. Walvax

  • Website: en.walvax.com
  • Ownership type: Private
  • Headquarters: Kunming, Yunnan, China
  • Employee distribution: China 95%, Philippines 5%
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn: walvax-biotechnology-co-ltd

Walvax Biotechnology Co., Ltd., based in Kunming, Yunnan, China, is a prominent player in the vaccine industry. Founded in 2001, the company focuses on the research, development, manufacturing, and distribution of vaccines aimed at combating infectious diseases. With a portfolio that includes eight licensed vaccines, such as the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) and the Recombinant Human Papillomavirus Bivalent Vaccine (HPV2), Walvax has made significant strides in public health. The company operates four manufacturing centers across China, with a notable capacity of approximately 390 million doses annually at its Yuxi facility. Walvax is also investing heavily in R&D, dedicating over 20% of its revenue to this area, which supports the development of innovative vaccine solutions. Their products are distributed widely within China and exported to 20 countries, showcasing their commitment to global health initiatives. Furthermore, Walvax has received grants from the Bill & Melinda Gates Foundation to support WHO prequalification efforts, highlighting their active role in international vaccine collaboration.


12. CZ Vaccines

  • Website: czvaccines.com
  • Ownership type: Corporate
  • Headquarters: Sabaceda, Pontevedra, Spain
  • Employee distribution: Spain 99%, Other 1%
  • Latest funding: $167.0M, May 2020
  • Founded year: 1993
  • Headcount: 201-500
  • LinkedIn: cz-vaccines

CZ Vaccines, based in Sabaceda, Pontevedra, Spain, is a biotechnology firm founded in 1993. The company specializes in the development and manufacturing of vaccines and biological products aimed at improving health outcomes for both humans and animals. They offer contract development and manufacturing organization (CDMO) services, catering to a wide array of clients, including multinational corporations and government entities. CZ Vaccines is recognized for its robust research and development capabilities, focusing on innovative vaccine solutions to combat viral and bacterial diseases. Their portfolio includes a variety of vaccine platforms, such as conventional vaccines, live attenuated vaccines, recombinant protein subunit vaccines, and cutting-edge DNA vaccines. The company has also actively participated in projects related to COVID-19, showcasing their commitment to addressing urgent health needs. With a workforce of approximately 152 employees, CZ Vaccines operates primarily in Spain, contributing significantly to the biotechnology sector.


13. Zendal

  • Website: zendal.com
  • Ownership type: Private
  • Headquarters: Torneiros, Ourense, Spain
  • Employee distribution: Spain 78%, Portugal 22%
  • Founded year: 1993
  • Headcount: 501-1000
  • LinkedIn: zendal

Zendal, founded in 1993 and based in Torneiros, Ourense, Spain, is a private biopharmaceutical company dedicated to the research, development, and manufacturing of vaccines and biological products for human and animal health. The company operates through several subsidiaries, including CZ Vaccines and Biofabri, which focus on vaccine development and production. With a workforce of over 650 professionals, Zendal emphasizes scientific excellence and innovation in its operations. The company has made significant strides in vaccine technology, including the development of MTBVAC, a vaccine for tuberculosis currently in clinical trials. Zendal's involvement in urgent health projects, such as those addressing the COVID-19 pandemic, highlights its responsiveness to global health needs. The company serves governments and multinational corporations, providing effective health solutions aimed at improving health outcomes worldwide.


14. NPO Petrovax Pharm LLC

  • Website: petrovax.ru
  • Ownership type: Venture Capital
  • Headquarters: Moscow, Moscow, Russia
  • Latest funding: February 2014
  • Founded year: 1996
  • Headcount: 501-1000
  • LinkedIn: npo-petrovax-pharm-llc

NPO Petrovax Pharm LLC, founded in 1996 and based in Moscow, Russia, is a biotechnology company that focuses on the development and manufacturing of original pharmaceuticals and vaccines. The company operates a full-cycle production facility that meets international standards, ensuring high-quality output. Petrovax is recognized for its innovative treatments targeting significant health issues, particularly in the vaccine sector. They produce vaccines for infectious diseases, including the Grippol® series for influenza and the pneumococcal vaccine Prevenar® 13. The company has a robust R&D center and has established partnerships with major global pharmaceutical firms, enhancing its capabilities in vaccine development and production. Petrovax also emphasizes the importance of quality control and compliance with regulatory standards, which is critical in the pharmaceutical industry.


15. MSD Sharp & Dohme GmbH

  • Website: msd.de
  • Ownership type: Private
  • Headquarters: Amt Neuhaus, Lower Saxony, Germany
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn: msd-sharp-%26-dohme-gmbh

MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, the company specializes in the research, development, and manufacturing of medications and vaccines. MSD is particularly focused on addressing health conditions in oncology and infectious diseases. The company is dedicated to enhancing global health outcomes by providing innovative healthcare solutions. MSD has made notable contributions to vaccine development, including efforts to combat diseases like Ebola, showcasing their commitment to public health. With a workforce of approximately 2,438 employees, MSD operates as one of the prominent pharmaceutical manufacturers in Germany, emphasizing the importance of vaccines in their product portfolio.


16. Petrovax Pharm

  • Website: petrovax.com
  • Ownership type: Private Equity
  • Headquarters: Moscow, Moscow, Russia
  • Employee distribution: Russia 96%, Uzbekistan 2%, Kazakhstan 2%
  • Latest funding: October 2022
  • Founded year: 1996
  • Headcount: 501-1000
  • LinkedIn: npo-petrovax-pharm-llc

Petrovax Pharm, founded in 1996 and based in Moscow, Russia, is a biotechnology company that focuses on the development and manufacturing of original pharmaceutical products and vaccines. The company operates a full-cycle biotechnological manufacturing facility that adheres to EAEU and EU GMP standards, ensuring high-quality production processes. Petrovax's product range includes vaccines aimed at preventing influenza, such as Grippol® plus and Grippol® Quadrivalent, as well as other pharmaceutical products and food supplements. The company has established partnerships with major international pharmaceutical firms, including Pfizer and Abbott, to enhance its capabilities and expand its market reach. Petrovax is also involved in research and development, holding patents for various pharmaceutical technologies and actively participating in clinical studies. Their commitment to quality and innovation positions them as a significant player in the vaccine production industry.


17. Intravacc

  • Website: intravacc.nl
  • Ownership type: Private
  • Headquarters: Bilthoven, Utrecht, Netherlands
  • Employee distribution: Netherlands 100%
  • Latest funding: Other (Grant), $633,000, January 2024
  • Founded year: 2013
  • Headcount: 51-200
  • LinkedIn: intravacc

Intravacc, founded in 2013 and based in Bilthoven, Utrecht, Netherlands, is a private company specializing in vaccine development and manufacturing. With a workforce of around 64 employees, Intravacc operates as a contract development and manufacturing organization (CDMO) focused on therapeutic and infectious disease vaccines. The company offers a comprehensive range of services, from initial vaccine development to Good Manufacturing Practice (GMP) compliant manufacturing. Intravacc has a notable pipeline of proprietary vaccine candidates, including those targeting COVID-19 and gonorrhea, and has established partnerships to enhance vaccine development. Their commitment to advancing public health is evident in their innovative approaches and the significant number of scientific publications they have contributed to the field. Recently, Intravacc secured $633,000 in funding from CARB-X to support the development of a vaccine aimed at preventing gonorrhea infections, highlighting their active role in addressing global health challenges.


18. GSK Canada

  • Website: gsk.ca
  • Ownership type: Private
  • Headquarters: Mississauga, Ontario, Canada
  • Founded year: 1906
  • Headcount: 1001-5000
  • LinkedIn: gsk-canada

GSK Canada, based in Mississauga, Ontario, is a biopharmaceutical company that specializes in the development of innovative vaccines and specialty medicines. Founded in 1906, GSK Canada has a long history in the pharmaceutical industry. The company is dedicated to improving health outcomes through advanced research and development, particularly in therapeutic areas such as infectious diseases and oncology. GSK Canada has made substantial investments in research and development, contributing over $2 billion to Canadian pharmaceutical and vaccine initiatives since 2001. Their product offerings include a range of vaccines targeting various infectious diseases, showcasing their commitment to public health and disease prevention.


19. Bilthoven Biologicals

  • Website: bbio.nl
  • Ownership type: Corporate
  • Headquarters: Bilthoven, Utrecht, Netherlands
  • Employee distribution: Netherlands 100%
  • Latest funding: $88.0M, March 2018
  • Founded year: 2012
  • Headcount: 201-500
  • LinkedIn: bilthoven-biologicals

Bilthoven Biologicals, founded in 2012 and located in Bilthoven, Utrecht, Netherlands, is a corporate entity specializing in vaccine manufacturing. The company produces essential vaccines, including the Inactivated Poliomyelitis Vaccine (IPV), DTP (Diphtheria, Tetanus, and Pertussis), and BCG (Bacillus Calmette-Guérin) for tuberculosis and bladder cancer treatment. Bilthoven Biologicals collaborates with global health organizations, such as the Bill & Melinda Gates Foundation, WHO, and UNICEF, to support vaccination programs aimed at eradicating diseases and enhancing public health. With a workforce of approximately 386 employees, the company is dedicated to maintaining high production standards to meet worldwide health demands.


20. Arabio - Arab Company for Pharmaceutical Products


Arabio - Arab Company for Pharmaceutical Products, founded in 2005 and based in Riyadh, Saudi Arabia, is a private pharmaceutical manufacturer with a strong focus on vaccines and biological products. The company operates primarily in the MENA region, supplying essential vaccines to healthcare providers and government health departments. Arabio is dedicated to improving public health by tackling vaccine-preventable diseases through its product range, which includes ten vaccines that are integral to the basic vaccination schedule in Saudi Arabia. The company has made significant strides in the vaccine market, having signed multiple agreements with global pharmaceutical firms such as Novartis, GSK, and AbbVie to manufacture and promote vaccines in the region. Arabio's facility in Makkah is the first biopharmaceutical plant in the GCC, equipped with advanced manufacturing capabilities. Their commitment to quality and compliance is reflected in their robust quality assurance processes, ensuring that their vaccines meet high standards. With a workforce primarily based in Saudi Arabia, Arabio is positioned to play a crucial role in enhancing vaccine accessibility and public health in the region.


21. Ibss Biomed S.A.

  • Website: biomed.pl
  • Ownership type: Private
  • Headquarters: Kraków, Lesser Poland Voivodeship, Poland
  • Employee distribution: Poland 100%
  • Founded year: 1949
  • Headcount: 201-500
  • LinkedIn: ibssbiomed

Ibss Biomed S.A., based in Kraków, Poland, is a biotechnology firm that has been operational since 1949. The company specializes in the production of vaccines, medicines, and probiotics, catering to both healthcare providers and consumers. With over 80 years of experience, Ibss Biomed has developed a portfolio that includes ten types of vaccines aimed at ensuring public health and safety. Their products are manufactured under strict quality control measures, complying with Good Manufacturing Practices (GMP). The company has a notable history of producing vaccines for various diseases, including those that are critical for epidemiological safety in Poland. They also engage in scientific and commercial collaborations across multiple countries, enhancing their reach and impact in the global market.


22. Vaxxas

  • Website: vaxxas.com
  • Ownership type: Venture Capital
  • Headquarters: Brisbane, Queensland, Australia
  • Employee distribution: Australia 95%, United States (USA) 5%
  • Latest funding: Other (Grant), $2.0M, January 2025
  • Founded year: 2011
  • Headcount: 51-200
  • LinkedIn: vaxxas

Vaxxas is a biotechnology firm based in Brisbane, Queensland, Australia, founded in 2011. The company is dedicated to advancing vaccine delivery technologies, particularly through its proprietary high-density microarray patch (HD-MAP). This innovative platform allows for needle-free vaccination, which could significantly enhance vaccine accessibility and effectiveness. Vaxxas is currently involved in various clinical trials, including those for seasonal influenza, COVID-19, and typhoid fever vaccines. The company has received funding, including a recent grant of $3.67 million from the Wellcome Foundation to support a clinical study for a typhoid vaccine. Vaxxas aims to address critical public health challenges by improving the delivery and stability of vaccines, particularly in regions with limited healthcare infrastructure.


23. Inventprise

  • Website: inventprise.com
  • Ownership type: Private
  • Headquarters: Redmond, Washington, United States (USA)
  • Employee distribution: United States (USA) 99%, Other 1%
  • Founded year: 2012
  • Headcount: 51-200
  • LinkedIn: inventprise-llc

Inventprise, founded in 2012 and based in Redmond, Washington, is a private biotechnology company dedicated to the development and manufacturing of vaccines. With a workforce of approximately 187 employees, Inventprise focuses on creating innovative vaccines, including their lead candidate, the Pneumococcal Conjugate Vaccine for Paediatric use. They utilize proprietary technologies, such as their Linker Conjugation Platform, to enhance vaccine efficacy and coverage. The company provides a range of services, including process development, clinical and commercial manufacturing, and quality assurance, primarily targeting healthcare providers and pharmaceutical organizations. Their commitment to advancing vaccine technology and improving public health outcomes underscores their relevance in the vaccine production industry.


24. Incepta Vaccine Ltd

  • Website: inceptavaccine.com
  • Ownership type: Private
  • Headquarters: Dhaka, Dhaka, Bangladesh
  • Employee distribution: Bangladesh 100%
  • Founded year: 2011
  • Headcount: 1001-5000
  • LinkedIn: incepta-vaccine-ltd

Incepta Vaccine Ltd, established in 2011, is a private pharmaceutical company based in Dhaka, Bangladesh. It specializes in the production of vaccines for both human and animal use, aiming to address the pressing need for effective immunization in Bangladesh and other developing regions. The company operates a state-of-the-art manufacturing facility that adheres to WHO GMP standards, ensuring the quality and safety of its products. Incepta's vaccine division is notable for its capacity to produce up to 180 million single-dose vials and ampoules each year. The company is committed to innovation and has developed a robust R&D facility capable of handling multiple projects simultaneously. Incepta's mission is to make vaccines accessible and affordable, thereby contributing to public health and the fight against infectious diseases. Their corporate social responsibility initiatives further reflect their commitment to the community and the health of the nation.


25. Center of Molecular Immunology


The Center of Molecular Immunology (CIM), founded in 1994 and based in Havana, Cuba, is a private biotechnology company dedicated to the research, development, and production of therapeutic vaccines and biological products. With a workforce of over 500 employees, CIM has established itself as a significant player in the field of immunotherapy, particularly focusing on treatments for cancer and diseases affecting the immune system. The company is known for its innovative therapeutic vaccines, such as CIMAvax EGF and VAXIRA, which are specifically designed for patients with advanced non-small cell lung cancer. These vaccines have received sanitary registration for use in stages III and IV of the disease, demonstrating CIM's commitment to improving patient outcomes through advanced therapeutic options. CIM operates under stringent Good Production Practices, ensuring that their products meet high standards of quality and safety. Their work is not only limited to vaccine production; they are also involved in clinical trials and collaborations aimed at expanding their therapeutic offerings.


26. Afrigen Biologics (Pty) Ltd

  • Website: afrigen.co.za
  • Ownership type: Private
  • Headquarters: Cape Town, Western Cape, South Africa
  • Employee distribution: South Africa 100%
  • Founded year: 2014
  • Headcount: 11-50
  • LinkedIn: afrigen-biologics-pty-ltd

Afrigen Biologics (Pty) Ltd, founded in 2014 and based in Cape Town, South Africa, is a biotechnology company dedicated to the development and manufacturing of vaccines and biotherapeutics for both human and animal health. The company is particularly noted for its focus on mRNA vaccine technology, which has gained prominence in recent years. Afrigen operates a technology transfer hub aimed at building mRNA vaccine production capacity in low- and middle-income countries, thereby addressing critical health needs in these regions. They collaborate with various global health organizations, including the WHO and CEPI, to enhance vaccine accessibility and affordability. Afrigen's facilities include research and product development labs, GMP vaccine manufacturing, and a compounding pharmacy, all designed to support their mission of providing high-quality vaccines and biotherapeutics. Their commitment to a 'one health' approach reflects an understanding of the interconnectedness of human and animal health, further solidifying their role in the vaccine production industry.


27. VitriVax

  • Website: vitrivaxbio.com
  • Ownership type: Venture Capital
  • Headquarters: Boulder, Colorado, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Other (Grant), $3.6M, December 2024
  • Founded year: 2017
  • Headcount: 11-50
  • LinkedIn: vitrivax

VitriVax, founded in 2017 and based in Boulder, Colorado, is a biotechnology firm dedicated to advancing vaccine development through innovative formulation technologies. The company specializes in creating thermostable and single-dose vaccines, addressing critical barriers to global vaccination. Their proprietary ALTA™ technology encapsulates antigens in a protective matrix, allowing for long-term stability and ease of transport, which is vital for reaching remote areas. VitriVax has received significant funding, including a recent $3.6 million grant, to support their research and development efforts. They actively collaborate with healthcare organizations and vaccine manufacturers, aiming to improve public health outcomes through their advanced vaccine technologies.



Vaccine Production Insights: Key Companies


CompanyHeadquarterSizeFoundedOwnership
Serum Institute of India Pvt. Ltd.Pune, Maharashtra, India1001-50001966Private
Bharat BiotechHyderabad, Telangana, India1001-50001996Venture Capital
Biological E. LimitedHyderabad, Telangana, India1001-50001953Venture Capital
BiovacCape Town, Western Cape, South Africa201-5002003Corporate
Indian Immunologicals LimitedHyderabad, Telangana, India1001-50001982Private
SINERGIUM BiotechGarin, Buenos Aires, Argentina201-5002011Private
AJ VaccinesFrederiksberg, Frederiksberg, Denmark501-10002017Private
VabiotechTrung Hoà, Hanoi, Vietnam1-102000Private
FORT Biopharmaceutical companyMoscow, Moscow, Russia201-5002006Private
HipraAmer, Catalonia, Spain1001-50001954Private
WalvaxKunming, Yunnan, China1001-50002001Private
CZ VaccinesSabaceda, Pontevedra, Spain201-5001993Corporate
ZendalTorneiros, Ourense, Spain501-10001993Private
NPO Petrovax Pharm LLCMoscow, Moscow, Russia501-10001996Venture Capital
MSD Sharp & Dohme GmbHAmt Neuhaus, Lower Saxony, Germany1001-50002001Private
Petrovax PharmMoscow, Moscow, Russia501-10001996Private Equity
IntravaccBilthoven, Utrecht, Netherlands51-2002013Private
GSK CanadaMississauga, Ontario, Canada1001-50001906Private
Bilthoven BiologicalsBilthoven, Utrecht, Netherlands201-5002012Corporate
Arabio - Arab Company for Pharmaceutical ProductsRiyadh, Riyadh, Saudi Arabia51-2002005Private
Ibss Biomed S.A.Kraków, Lesser Poland Voivodeship, Poland201-5001949Private
VaxxasBrisbane, Queensland, Australia51-2002011Venture Capital
InventpriseRedmond, Washington, United States (USA)51-2002012Private
Incepta Vaccine LtdDhaka, Dhaka, Bangladesh1001-50002011Private
Center of Molecular ImmunologyHavana, Havana, Cuba1001-50001994Private
Afrigen Biologics (Pty) LtdCape Town, Western Cape, South Africa11-502014Private
VitriVaxBoulder, Colorado, United States (USA)11-502017Venture Capital


Want to Find More Vaccine Production Companies?

If you want to find more companies that offer vaccines and biopharmaceutical products targeting various diseases you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!